Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809

Surgery

Volumn 123, Issue 2, 1998, Pages 218-227

  Fulton, G J ^a   Davies, M G ^a   Barber, L ^a   Svendsen, E ^a   Hagen, P O ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CAROTID ARTERY; CONTROLLED STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; TOPICAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VEIN GRAFT;

EID: 0031887226     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(98)70261-2     Document Type: Article

References (31)

1. DF Bandyk JL Mills The failing graft: detection and management Semin Vasc Surg 6 1993 75 140
2. MG Davies P-O Hagen Pathophysiology of vein graft failure Eur J Vasc Endovasc Surg 9 1995 7 18
3. JA Mannick Improved limb salvage from modern infrainguinal artery bypass techniques Surgery 111 1992 361 362
4. MG Davies P-O Hagen Kinetics of altered angiotensin II responses in experimental vein grafts J Invest Surg 9 1996 423 432
5. MG Davies GJ Fulton E Barber H Dalen E Svendsen P-O Hagen Suppression of angiotensin II responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809 Eur J Vasc Endovasc Surg 12 1996 151 161
6. MK O'Donohoe LB Schwartz ZS Radic EM Mikat RL McCann P-O Hagen Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts Ann Surg 214 1991 727 732
7. MG Davies L Barber H Dalen E Svendsen P-O Hagen Pharmacologic control of the structural and functional consequences of vein graft intimal hyperplasia by a 21-amino steroid (U74389G) Eur J Vasc Surg 8 1994 156 165
8. MG Davies JH Kim L Barber H Dalen E Svendsen P-O Hagen Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts J Surg Res 57 1994 106 121
9. DJ Finney Quantal responses and the tolerance distribution DJ Finney Statistical methods in biological assay 1978 Charles Griffin London 349 369
10. MG Davies P-O Hagen The vascular endothelium: a new horizon Ann Surg 218 1993 593 609
11. MG Davies E Barber H Dalen E Svendsen P-O Hagen Lazaroid therapy (methylaminochroman: U83836E) reduces experimental vein graft intimal hyperplasia J Surg Res 63 1996 128 136
12. MG Davies H Dalen A-M Austarheim TF Gulbrandsen E Svendsen P-O Hagen Suppression of intimal hyperplasia in experimental vein grafts by oral L -arginine supplementation and single ex-vivo immersion in deferoxamine manganese J Vasc Surg 23 1996 410 420
13. KK Griendling TJ Murphy RW Alexander Molecular biology of the renin angiotensin system Circulation 87 1993 1816 1828
14. H Itoh M Mukoyoma RE Pratt G Gibbons VJ Dzau Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II J Clin Invest 91 1993 2268 2274
15. M Daemon DM Lombardi FT Bosman SM Schwartz Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall Circ Res 68 1991 450 456
16. VJ Dzau GH Gibbons RE Pratt Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia Hypertension 18 suppl 1991 100 105
17. VJ Dzau Evolving concepts of the renin-angiotensin system Am J Hypertens 1 1988 334S 337S
18. RF Kauffman JS Bean KM Zimmerman RF Brown MI Steinberg Losartan, a nonpeptide angiotensin II receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries Life Sci 49 1991 223 228
19. SD Bilazarian JW Currier T Kakuta CC Haudenschild DP Faxon Angiotensin II antagonism does not prevent restenosis after rabbit iliac angioplasty [abstract] Circulation 86 suppl 1992 I-187
20. K Varty KE Allen L Jones RD Sayers PR Bell NJ London Influence of losarten, an angiotensin receptor antagonist, in neointimal proliferation in cultured saphenous vein Br J Surg 81 1994 819 822
21. MF Prescott RL Webb MA Reidy Angiotensin-converting enzyme inhibitor versus angiotensin II: AT1 receptor antagonist effects on smooth muscle cell migration and proliferation after balloon catheter injury Am J Pathol 139 1991 1291 1296
22. J Taguchi J Abe H Okazaki Angiotensin converting enzyme inhibitors or DuP753 prevent neointimal formation following balloon injury with single topical or multiple systemic application Biochem Biophys Res Commun 196 1993 969 974
23. P Janiak A Pillon JF Prost JP Vilaine Role of angotensin subtype 2 receptor in neointima formation after vascular injury Hypertension 20 1992 737 745
24. MK O'Donohoe ZS Radic AD Stein LB Schwartz RL McCann P-O Hagen Loss of tachyphylaxis and increased sensitivity to angiotensin II in experimental vein grafts Vasc Surg 25 1991 281 287
25. RSL Chang PKS Siegl BV Clineschmidt In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist J Pharmacol Exp Ther 262 1992 133 138
26. PKS Siegl RSL Chang NB Mantlo In vivo pharmacology of L158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist J Pharmacol Exp Ther 262 1992 139 144
27. EA Hauser MJ Turner JM Trzashs WF Herblin Angiotensin II receptors in rabbit vein grafts Biochem Biophys Res Commun 190 1993 27 32
28. RL Panek GH Lu RW Overhiser TC Major JC Hodges DG Taylor Functional studies but not receptor binding can distinguish surmountable from in surmountable AT1 antagonism J Pharmacol Exp Ther 273 1995 753 761
29. MN El Sanadiki KS Cross EM Mikat P-O Hagen Verapamil therapy reduces intimal hyperplasia in balloon injured rabbit aorta [abstract] Circulation 76 suppl 1987 314
30. MF Massey MG Davies E Svendsen ML Klyachkin L Barber P-O Hagen Ketanserin inhibits experimental vein graft intimal hyperplasia J Surg Res 54 1993 530 538
31. MG Davies JH Kim RG Makhoul H Dalen E Svendsen P-O Hagen Reduction of intimal hyperplasia and preservation of nitric oxide (NO)-mediated relaxation by the NO precursor L -arginine Surgery 116 1994 557 568